Clinical trial
Phase II Study of Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer
NCT02423226 is registered in ClinicalTrials.gov with The First People's Hospital of Changzhou as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer
- Lead sponsor
- The First People's Hospital of Changzhou
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2008
- Completion date
- April 30, 2015
- Enrollment
- 56 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
rectum cancer